Hemodialysis

<!-- Name:DistributionId Value:8838299 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Elana Gotkine TUESDAY, Feb. 21, 2023 (HealthDay News) -- Disparities exist in Staphylococcus aureus bloodstream infections in patients with end-stage kidney disease (ESKD) on hemodialysis, according to…

New York, United States, Dec. 06, 2022 (GLOBE NEWSWIRE) -- A hemodialysis is a form of treatment used to remove water and waste from the blood. During kidney failure, dialysis removes wastes such as urea and creatinine as well as free…

New York, USA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- The Global Hemodialysis Machines Market to Grow at a Paltry CAGR of 4.71% During the Forecast Period (2022–2027), Assesses DelveInsight The hemodialysis machines is predicted to surge due…

Pune, June 30, 2022 (GLOBE NEWSWIRE) -- Hemodialysis And Peritoneal Dialysis Market by Vendor Assessment, Technology Assessment, Partner & Customer Ecosystem, type/solution, service, organization size, end-use verticals, and Region –…

New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Hemodialysis and Peritoneal…

Selbyville, Delaware, May 18, 2022 (GLOBE NEWSWIRE) -- The hemodialysis catheters market value is projected to reach USD 1.3 billion by 2028, according to a new research report by Global Market Insights Inc. Facilitative initiatives…

First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patientsFirst launches in Europe expected in H2 2022 ST. GALLEN, Switzerland and STAMFORD, Conn., April 28, 2022…

Pune, India, March 03, 2022 (GLOBE NEWSWIRE) -- The rising prevalence of renal and chronic kidney disease is a key factor driving the global hemodialysis equipment market, says Fortune Business Insights in a report, titled “Hemodialysis…

Committee for Medicinal Products for Human Use (CHMP) recommends approval of Kapruvia® (difelikefalin) as first therapy in Europe for the treatment of chronic kidney disease associated-pruritus (CKD-aP) in hemodialysis patientsEuropean…